To review the antidepressant efficacy of S-Adenosyl-L-Methionine (SAMe) both in monotherapy and/or in augmentation with antidepressants to better understand its potential role in the treatment of patients with Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder / De Berardis, D., Orsolini, L., Serroni, N., Girinelli, G., Iasevoli, F., Tomasetti, C., DE BARTOLOMEIS, A., Mazza, M., Valchera, A., Fornaro, M., Perna, G., Piersanti, M., Di Nicola, M., Cavuto, M., Martinotti, G., Di Giannantonio, M.. - In: CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS. - ISSN 1996-3181. - 15:1(2016), pp. 35-44. [10.2174/1871527314666150821103825]
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder
IASEVOLI, FELICE;TOMASETTI, CARMINE;DE BARTOLOMEIS, ANDREA;Fornaro, Michele;
2016
Abstract
To review the antidepressant efficacy of S-Adenosyl-L-Methionine (SAMe) both in monotherapy and/or in augmentation with antidepressants to better understand its potential role in the treatment of patients with Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).| File | Dimensione | Formato | |
|---|---|---|---|
|
Full-text FINALE.pdf
non disponibili
Tipologia:
Documento in Pre-print
Licenza:
Accesso privato/ristretto
Dimensione
353.59 kB
Formato
Adobe PDF
|
353.59 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
